Scale -

  • Revenue is 206 Rs Cr; Annual Growth is 37 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 14 %
  • Ebitda is 22.96 Rs Cr; Annual Growth is 30 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 26 %
  • PBT is 3.34 Rs Cr; Annual Growth is 34 %; in Top Quartile; 5 Year CAGR is 29 %
  • PAT is 13.12 Rs Cr; Annual Growth is 30 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 28 %
  • Quarterly Revenue is 69.4 Rs Cr; in Top Quartile

Profitability -

  • PBDIT Margin is 11.12 %; 5 Year CAGR is 10 %
  • PAT Margin is 6.35 %; 5 Year CAGR is 12 %

Return -

  • ROCE is 26.22 %; Continuous Growth over 3 years; in Top Quartile
  • ROE is 17.37 %; Continuous Growth over 3 years; in Top Quartile
  • ROA is 8.54 %; in Top Quartile
  • Asset Turnover is 151 %; in Top Quartile

Efficiency -

  • Inventory Turnover Ratio is 7.27; Continuous Growth over 3 years; in Top Quartile
  • Operating cash flow is 5.87 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 36 %
  • Current Ratio is 1.66; Continuous Decline over 3 years

Solvancy -

  • Long term Debt is 0.29 Rs Cr; 5 Year CAGR is -25 %
  • Total Debt is 18.84 Rs Cr; Annual Growth is 36 %; Continuous Growth over 3 years
  • Contingent Liabilities is 3.36 Rs Cr; Annual Growth is 4100 %; Continuous Growth over 3 years; in Top Quartile
  • Debt/Equity is 0.25; Continuous Growth over 3 years

Quality -

  • Change in Inventories/Total Expenses is -1 %; Annual Growth is 77 %
  • Current Tax/PAT is 38 %; Continuous Growth over 3 years; in Top Quartile
  • Other Expenses/Total Expenses is 8 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Medico Remedies (MEDICO.NS) Eases Marginally to ?20.48 as Stock Consolidates Below ?21.50 Resistance
Read More
  • Past/current
Medico Remedies Ltd. Estimates – NSE:MEDICO
Read More
  • Past/current